Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phase I study of vandtanib with radiation therapy and temozolomide for newly-diagnosed glioblastoma

Phase I study of vandtanib with radiation therapy and temozolomide for newly-diagnosed glioblastoma. Proceed ASCO. 2009; 27:94s.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.